Wednesday, 27 Jan 2021 07:34 AM MYT
Johnson & Johnson also provided a strong lift, up 2.71 per cent as the drugmaker said it expected to report eagerly awaited Covid-19 vaccine data early next week. “It is still somewhat the early days but we are getting into the heart of it here,” said Tim Ghriskey, chief investment strategist at Inverness Counsel in New York.
After the closing bell, Microsoft shares rose 5.20 per cent as the tech giant beat Wall Street estimates for revenue growth in its Azure cloud comuting business as it benefits from a global shift to home learning and working.